Physician profile
Joseph Asprec
NPI 1295805679
$2,995.49
in general payments reported to CMS, 2019-2025
16 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $542 · 2021: $558 · 2022: $499 · 2023: $14.10 · 2024: $170 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $861.20 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $623.29 | 2019-2022 | |
| Amgen INC. | $602.21 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $233.06 | 2020-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $186.01 | 2022 | |
| Merck Sharp & Dohme LLC | $87.80 | 2019-2020 | |
| Amarin Pharma, INC. | $80.87 | 2020 | |
| Eisai INC. | $63.87 | 2020-2021 | |
| Glaxosmithkline, LLC. | $63.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $46.44 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $42.43 | 2019 | |
| Exact Sciences Corporation | $29.31 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $23.80 | 2021 | |
| Sun Pharmaceutical Industries INC. | $22.80 | 2021 | |
| Abbott Laboratories | $15.20 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $13.88 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Asprec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.